American Funds Growth Fd of Amer C (GFACX)

Nasdaq • Currently down 1.58 (-2.15%) in today's trading session

3 members of Congress have disclosed 6 trades in American Funds Growth Fd of Amer C (GFACX) via STOCK Act filings. The most recent disclosure was a sale by Rashida Tlaib on 28 April 2025. The most active traders have been Jason Crow (3), Rashida Tlaib (2), and Joe Courtney (1). Aggregate disclosed activity totals roughly $72.5K in sales (midpoint estimates from bracketed disclosure amounts).

American Funds Growth Fd of Amer C is currently trading at $71.77, positioned at 68% of its 52-week range ($59.64 – $77.39).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$71.77
24h Change
-1.58 (-2.15%)
52 Week Range
$59.64–$77.39
View on NASDAQ

American Funds Growth Fd of Amer C Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GFACX

Select to highlight on chart
5 transactions
Compliance: 0%
Rashida Tlaib28 Apr 202520 Aug 2026SaleStock$1,001 - $15,000N/A
Rashida Tlaib28 Apr 202511 Aug 2026SaleStock$1,001 - $15,000N/A
Jason Crow5 Aug 201924 Nov 2020SaleStock$15,001 - $50,000N/A
Jason Crow23 May 201924 Nov 2020SaleStock$1,001 - $15,000N/A
Jason Crow28 Jan 201924 Nov 2020SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$254.08B

Volume

0

Beta

1.16

P/E Ratio

29.52

Fundamentals

EPS

$2.43

Div. Yield

11.65%

Open

$73.35

Day Range

$71.77 – $73.35

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2001-03-15

This fund primarily focuses its investments on common equities, aiming to acquire shares in companies that present strong potential for significant capital appreciation. Up to a quarter of its total assets may be allocated to international securities...

No earnings data available for this stock.

Dividends

Dividend History

17 Dec 2025
Amount $8.3640
18 Dec 2024
Amount $6.3810
15 Dec 2023
Amount $4.3010
16 Dec 2022
Amount $1.8410
17 Dec 2021
Amount $6.0140
18 Dec 2020
Amount $2.7350
20 Dec 2019
Amount $3.2784
21 Dec 2018
Amount $4.8200
20 Dec 2017
Amount $3.2340
21 Dec 2016
Amount $2.5292
22 Dec 2015
Amount $3.3910
18 Dec 2014
Amount $4.0570
19 Dec 2013
Amount $2.7480
20 Dec 2012
Amount $0.0102
22 Dec 2010
Amount $0.0244
22 Dec 2009
Amount $0.0442
23 Dec 2008
Amount $0.0106
19 Dec 2007
Amount $2.1562
19 Dec 2006
Amount $1.1405
19 Dec 2005
Amount $0.2250
22 Apr 2005
Amount $0.0370

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about GFACX

Which members of Congress have traded GFACX?
3 members of Congress have disclosed 6 trades in American Funds Growth Fd of Amer C (GFACX) under the STOCK Act. The most active traders are Jason Crow, Rashida Tlaib, and Joe Courtney.
When was GFACX most recently disclosed by Congress?
The most recent GFACX disclosure was a sale by Rashida Tlaib on 28 April 2025.
What is the total disclosed congressional trading volume for GFACX?
Members of Congress have disclosed approximately $72.5K in GFACX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in GFACX?
This GFACX page updates as soon as new STOCK Act disclosures are filed for American Funds Growth Fd of Amer C. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.